CLICS Archive
Dashboard
Bill Archiver
Bill Runs
Bill Archives
Bills
Schedules
Schedule Runs
Schedules
Committees
Committee Runs
Committees
Meeting Runs
Meetings
Legislators
Legislator Runs
Legislators
Settings
Back to Archives
Archive #40268
Metadata
Bill Number
SB26-066
HTTP Status
200
Valid JSON
Valid
Archived At
2026-03-05 19:36:00 MST
Created At
2026-03-05 19:36:00 MST
Parsed JSON
{ "votes": [], "active": "T", "origin": "Senate", "lls_num": "26-0540", "session": "2026A", "subject": [ "Civil Law", "Public Health" ], "bill_num": "SB26-066", "sponsors": [ { "id": "IJ001", "title": "Senator", "s_type": "Prime Sponsor", "chamber": "Senate", "full_name": "Iman Jodeh", "last_name": "Jodeh", "first_name": "Iman", "sponsor_order": "1" }, { "id": "JC004", "title": "Senator", "s_type": "Prime Sponsor", "chamber": "Senate", "full_name": "John Carson", "last_name": "Carson", "first_name": "John", "sponsor_order": "2" } ], "bill_files": [ { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.pdf", "date": "01/28/2026", "label": "Introduced", "url_html": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.html", "lastModified": "01/28/2026 12:26:00 PM" } ], "committees": [ { "id": "S_HHS_2026A", "name": "Health & Human Services", "chamber": "Senate" } ], "long_title": "Concerning the regulation of compounded weight-loss medications that have not been approved by the United States food and drug administration.", "bill_status": "In Committee - SEN Health & Human Services", "short_title": "Regulation of Compounded Weight-Loss Medication", "bill_summary": "<html><body><p><t></t></p><p>The bill establishes regulations for the sale, transfer, or distribution of compounded weight-loss medications, which are custom-made medications that, unlike mass-produced medications, are not subject to approval by the federal food and drug administration (FDA). A person may not sell, transfer, or distribute a compounded weight-loss medication unless the person confirms that the medication:</p><p><ul><li>Is made from bulk drug substances and drugs that are approved by the FDA when such approval is required;<li>Was manufactured in compliance with FDA processes; <li>Contains bulk drug substances that are pharmaceutical grade and are accompanied by a certificate of analysis containing information that is material to the safety and efficacy of the bulk drug substances;<li>Was manufactured at a facility that is registered with the FDA and passed an FDA inspection within the previous 2 years; and<li>Is verified for purity and accurate dosage.</li></ul><t></t></p><p>Labels for compounded weight-loss medications must list all active and inactive ingredients, the quantity of those ingredients, and the ingredients' country of origin. There must also be a warning on the label stating that the compounded weight-loss medication has not been FDA-approved, has inadequate evidence of safety or efficacy, and has known and unknown side effects. A person must also provide certain disclosures to a patient when prescribing compounded weight-loss medications.</p><p><t></t></p><p>The bill prohibits the use of false or misleading claims, including unsubstantiated claims, when advertising or promoting compounded weight-loss medications.</p><p><t></t></p><p>A person that sells, transfers, or distributes compounded weight-lost medication must keep records related to the compounded weight-loss medication for at least 2 years after the date of expiration of the compounded weight-loss medication and make those records available for inspection by the state board of pharmacy.</p><p><t></t></p><p>The state board of pharmacy may issue fines of up to $1,000 per dose of compounded weight-loss medications that are sold or distributed in violation of the bill and may revoke a pharmacy or business license for violations.</p><p><t></t></p><p>The attorney general has authority to enforce this bill as a deceptive trade practice under the "Colorado Consumer Protection Act".</p><p><br/><i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>", "progress_bar": [ { "end": "F", "label": "Introduced", "position": 1 }, { "end": "F", "label": "Under Consideration", "position": 2 } ], "special_type": "", "bill_category": "Consumer & Commercial Transactions", "allow_testimony": "F", "amendment_files": [ { "url": "https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/35DEE2353A45B10A87258DB000712973/SB066_L.003.pdf", "date": "03/05/2026 07:30:20 PM", "vote": "Passed*", "chamber": "Senate", "hearing": "SEN Health & Human Services", "url_html": "https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/35DEE2353A45B10A87258DB000712973/SB066_L_003.html", "amendment": "L.003" } ], "full_bill_topic": "Regulation of Compounded Weight-Loss Medication", "long_bill_files": [], "GHG_report_files": [], "preamended_files": [], "bill_sub_category": "Consumer Protection", "fiscal_note_files": [ { "url": "https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/SB066_00.pdf", "date": "03/03/2026", "label": "FN1", "url_html": "", "lastModified": "03/03/2026 03:05:08 PM", "label_detailed": "Initial Fiscal Note" } ], "is_budget_package": "No", "session_laws_files": "", "summarized_history": [ { "date": "01/28/2026", "action": "Introduced In Senate - Assigned to Health & Human Services", "location": "Senate" } ], "research_note_files": [], "bill_sub_sub_category": "Other", "committee_report_files": [], "demographic_note_files": [], "updated_bill_summary_files": [], "budget_staff_analysis_files": [], "first_chamber_third_reading_date": "", "second_chamber_third_reading_date": "" }
Raw Response
{"bill_num":"SB26-066","lls_num":"26-0540","origin":"Senate","short_title":"Regulation of Compounded Weight-Loss Medication","full_bill_topic":"Regulation of Compounded Weight-Loss Medication","long_title":"Concerning the regulation of compounded weight-loss medications that have not been approved by the United States food and drug administration.","special_type":"","bill_category":"Consumer & Commercial Transactions","bill_sub_category":"Consumer Protection","bill_sub_sub_category":"Other","is_budget_package":"No","subject":["Civil Law","Public Health"],"bill_status":"In Committee - SEN Health & Human Services","sponsors":[{"id":"IJ001","title":"Senator","first_name":"Iman","last_name":"Jodeh","full_name":"Iman Jodeh","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"1"},{"id":"JC004","title":"Senator","first_name":"John","last_name":"Carson","full_name":"John Carson","s_type":"Prime Sponsor","chamber":"Senate","sponsor_order":"2"}],"committees":[{"id":"S_HHS_2026A","chamber":"Senate","name":"Health & Human Services"}],"first_chamber_third_reading_date":"","second_chamber_third_reading_date":"","summarized_history":[{"date":"01/28/2026","location":"Senate","action":"Introduced In Senate - Assigned to Health & Human Services"}],"progress_bar":[{"position":1,"label":"Introduced","end":"F"},{"position":2,"label":"Under Consideration","end":"F"}],"active":"T","session":"2026A","allow_testimony":"F","long_bill_files":[],"bill_files":[{"date":"01/28/2026","lastModified":"01/28/2026 12:26:00 PM","label":"Introduced","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.pdf","url_html":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/066_01.html"}],"fiscal_note_files":[{"date":"03/03/2026","lastModified":"03/03/2026 03:05:08 PM","label":"FN1","label_detailed":"Initial Fiscal Note","url":"https://www.leg.state.co.us/CLICS/CLICS2026A/csl.nsf/0/D48F126F849D246787258D49006A35B9/$File/SB066_00.pdf","url_html":""}],"research_note_files":[],"budget_staff_analysis_files":[], "preamended_files":[],"committee_report_files":[],"updated_bill_summary_files":[],"demographic_note_files":[],"GHG_report_files":[],"bill_summary":"<html><body><p><t></t></p><p>The bill establishes regulations for the sale, transfer, or distribution of compounded weight-loss medications, which are custom-made medications that, unlike mass-produced medications, are not subject to approval by the federal food and drug administration (FDA). A person may not sell, transfer, or distribute a compounded weight-loss medication unless the person confirms that the medication:</p><p><ul><li>Is made from bulk drug substances and drugs that are approved by the FDA when such approval is required;<li>Was manufactured in compliance with FDA processes; <li>Contains bulk drug substances that are pharmaceutical grade and are accompanied by a certificate of analysis containing information that is material to the safety and efficacy of the bulk drug substances;<li>Was manufactured at a facility that is registered with the FDA and passed an FDA inspection within the previous 2 years; and<li>Is verified for purity and accurate dosage.</li></ul><t></t></p><p>Labels for compounded weight-loss medications must list all active and inactive ingredients, the quantity of those ingredients, and the ingredients' country of origin. There must also be a warning on the label stating that the compounded weight-loss medication has not been FDA-approved, has inadequate evidence of safety or efficacy, and has known and unknown side effects. A person must also provide certain disclosures to a patient when prescribing compounded weight-loss medications.</p><p><t></t></p><p>The bill prohibits the use of false or misleading claims, including unsubstantiated claims, when advertising or promoting compounded weight-loss medications.</p><p><t></t></p><p>A person that sells, transfers, or distributes compounded weight-lost medication must keep records related to the compounded weight-loss medication for at least 2 years after the date of expiration of the compounded weight-loss medication and make those records available for inspection by the state board of pharmacy.</p><p><t></t></p><p>The state board of pharmacy may issue fines of up to $1,000 per dose of compounded weight-loss medications that are sold or distributed in violation of the bill and may revoke a pharmacy or business license for violations.</p><p><t></t></p><p>The attorney general has authority to enforce this bill as a deceptive trade practice under the "Colorado Consumer Protection Act".</p><p><br/><i>(Note: This summary applies to this bill as introduced.)</i></p></body></html>","amendment_files":[{"chamber":"Senate","date":"03/05/2026 07:30:20 PM","amendment":"L.003","hearing":"SEN Health & Human Services","vote":"Passed*","url":"https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/35DEE2353A45B10A87258DB000712973/SB066_L.003.pdf","url_html":"https://s3-us-west-2.amazonaws.com/leg.colorado.gov/2026A/amendments/35DEE2353A45B10A87258DB000712973/SB066_L_003.html"}],"session_laws_files":"","votes":[]}